Nova Mentis Life Science Corp. HN3Q.F Stock
Nova Mentis Life Science Corp. Price Chart
Nova Mentis Life Science Corp. HN3Q.F Financial and Trading Overview
| Nova Mentis Life Science Corp. stock price | 0.0050 EUR |
| Previous Close | 0.02 EUR |
| Open | 0.01 EUR |
| Bid | 0.0095 EUR x N/A |
| Ask | 0.04 EUR x N/A |
| Day's Range | 0.01 - 0.01 EUR |
| 52 Week Range | 0.0076 - 0.08 EUR |
| Volume | 74K EUR |
| Avg. Volume | 492 EUR |
| Market Cap | 3.24M EUR |
| Beta (5Y Monthly) | N/A |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.01 EUR |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
HN3Q.F Valuation Measures
| Enterprise Value | 2.43M EUR |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | N/A |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | N/A |
Trading Information
Nova Mentis Life Science Corp. Stock Price History
| Beta (5Y Monthly) | N/A |
| 52-Week Change | -58.85% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 0.08 EUR |
| 52 Week Low | 0.0076 EUR |
| 50-Day Moving Average | 0.02 EUR |
| 200-Day Moving Average | 0.02 EUR |
HN3Q.F Share Statistics
| Avg. Volume (3 month) | 492 EUR |
| Avg. Daily Volume (10-Days) | 2.76K EUR |
| Shares Outstanding | 147.52M |
| Float | N/A |
| Short Ratio | N/A |
| % Held by Insiders | 11.61% |
| % Held by Institutions | 0.0069% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 1:4 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | N/A |
| Return on Equity (ttm) | N/A |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | N/A |
| Net Income Avi to Common (ttm) | N/A |
| Diluted EPS (ttm) | -0.01 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | N/A |
| Total Cash Per Share (mrq) | N/A |
| Total Debt (mrq) | N/A |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | N/A |
| Book Value Per Share (mrq) | 0 |
Cash Flow Statement
| Operating Cash Flow (ttm) | N/A |
| Levered Free Cash Flow (ttm) | N/A |
Profile of Nova Mentis Life Science Corp.
| Country | Germany |
| State | BC |
| City | Vancouver |
| Address | 700-838 West Hasting Street |
| ZIP | V6C 0A6 |
| Phone | 778-819-0244 |
| Website | https://www.novamentis.ca |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | N/A |
Nova Mentis Life Science Corp., through its subsidiaries, operates as a biotechnology company worldwide. The comapny engages in developing diagnostics and psilocybin-based therapeutics for neuroinflammatory conditions with a focus on autism spectrum disorder and fragile X syndrome. It has a research agreement with the University of Central Florida (UCF) to develop a saliva serotonin assay. The company was formerly known as Liberty Leaf Holdings Ltd. and changed its name to Nova Mentis Life Science Corp. in June 2020. Nova Mentis Life Science Corp. was incorporated in 2004 and is headquartered in Vancouver, Canada.
Q&A For Nova Mentis Life Science Corp. Stock
What is a current HN3Q.F stock price?
Nova Mentis Life Science Corp. HN3Q.F stock price today per share is 0.0050 EUR.
How to purchase Nova Mentis Life Science Corp. stock?
You can buy HN3Q.F shares on the Frankfurt exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Nova Mentis Life Science Corp.?
The stock symbol or ticker of Nova Mentis Life Science Corp. is HN3Q.F.
Which industry does the Nova Mentis Life Science Corp. company belong to?
The Nova Mentis Life Science Corp. industry is Biotechnology.
How many shares does Nova Mentis Life Science Corp. have in circulation?
The max supply of Nova Mentis Life Science Corp. shares is 300.7M.
What is Nova Mentis Life Science Corp. Price to Earnings Ratio (PE Ratio)?
Nova Mentis Life Science Corp. PE Ratio is now.
What was Nova Mentis Life Science Corp. earnings per share over the trailing 12 months (TTM)?
Nova Mentis Life Science Corp. EPS is -0.01 EUR over the trailing 12 months.
Which sector does the Nova Mentis Life Science Corp. company belong to?
The Nova Mentis Life Science Corp. sector is Healthcare.